latest news on glp 1 drugs Risks of Ozempic, other GLP-1 are at center of sweeping lawsuit that kicked off in Philadelphia New oral GLP-1 drug delivers
Description
#FunctionalMedicine #WeightLoss #Tesofensine #ObesityTreatment #MetabolicHealth To view or add a comment, sign in Breakthrough from Eli Lilly: Oral GLP-1 Drug Orforglipron : Im excited to highlight this emerging therapy that carries significant implications for the treatment of obesity and type 2 diabetes
Recent funding from the Congressionally Directed Medical Research Program will support a multi-site study that should kick off by the end of the year, and Schacht suspects approval of a GLP-1 drug for AUD in less than three years
Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents
In a statement posted on its website on Tuesday (02/24), Sciwind called the deal "an important first step to advance Pfizer's global strategy in the metabolic field in China." Ecnoglutide itself already got the green light from Chinese regulators back in January 2026 for treating type 2 diabetes
triple agonism extends that to three
The protein DPP-4 is localized to a small pocket known as the catalytic pocket, which has serine at position 630
